Perbedaan Lini Imaji Kreasi Ekosistem Tbk. dan Indofarma Tbk.: Lini Imaji Kreasi Ekosistem Tbk. diperdagangkan di Rp294 (kapitalisasi pasar 1,99 T, volume 24 jam 36,36 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Lini Imaji Kreasi Ekosistem Tbk. jauh lebih besar — sekitar 5,1× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| FUTR | INAF | |
|---|---|---|
Kapitalisasi Pasar | 1,99 T | 390,51 M |
Volume | 36,36 jt | — |
Lot | 363,6 rb | — |
Perputaran | 10,52 M | — |
Harga Rata-rata | 289,44 | — |
Nilai Transaksi | 10,52 M | — |
Harga Ekuilibrium Indikatif | 294 | — |
Volume Ekuilibrium Indikatif | 6,93 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Lini Imaji Kreasi Ekosistem Tbk (the “Company”) was established under the name of PT LinikiniAspirasi Kreasi based on Notarial Deed No. 74 of Janty Lega, S.H., M.Kn., dated July 29, 2021. The Company started its commercial operations in 2021. The immediate and ultimate parent entities of the Company are PT Digital Futurama Global and PT Investasi Gemilang Maju, respectively.
Selengkapnya di halaman FUTR →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →